Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	84.14	-46.02	-290.25
Graham Fair Price	313.67	3.61	0.87
PEG	-99.50	< 0.005	-0.59
Price/Book	18.07	0.39	0.33
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-92.90	3.85	54.19
Price/Sales	-4.20	4.00	4.18
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	2056.24	0.33	0.02
ROA	1469.19	< 0.005	< 0.005
ROE	< 0.005	0.03	1563.88
ROIC	< 0.005	< 0.005	2190.36
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.33	0.55	-40.35
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.95	25.75	2597.52
EPS QOQ	-0.91	12.89	1311.32
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	-0.10	0.24	130.34
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.71	0.62	-12.48
Quick Ratio	52.06	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.72	4.78	1.41
Cash	14.88	16.77	12.68
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	0.37	0.46	24.99
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	52.06	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-565.68	-58.26	89.70
Naive Interpretation	Member

06 - Financial Health · Bad

Rating